pubmed.ncbi.nlm.nih.gov

Gynecomastia: Clinical evaluation and management - PubMed

Review

Gynecomastia: Clinical evaluation and management

Neslihan Cuhaci et al. Indian J Endocrinol Metab. 2014 Mar.

Abstract

Gynecomastia is the benign enlargement of male breast glandular tissue and is the most common breast condition in males. At least 30% of males will be affected during their life. Since it causes anxiety, psychosocial discomfort and fear of breast cancer, early diagnostic evaluation is important and patients usually seek medical attention. Gynecomastia was reported to cause an imbalance between estrogen and androgen action or an increased estrogen to androgen ratio, due to increased estrogen production, decreased androgen production or both. Evaluation of gynecomastia must include a detailed medical history, clinical examination, specific blood tests, imaging and tissue sampling. Individual treatment requirements can range from simple reassurance to medical treatment or even surgery. The main aim of any intervention is to relieve the symptoms and exclude other etiological factors.

Keywords: Androgen; drug; estrogen; gynecomastia; surgery.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1

Hormonal evaluation of gynecomastia

Similar articles

Cited by

References

    1. Braunstein GD. Clinical Practise. Gynecomastia. N Engl J Med. 2007;20(357):1229–37. - PubMed
    1. Carlson HE. Approach to the patient with gynecomastia. J Clin Endocrinol Metab. 2011;96:15–21. - PubMed
    1. Johnson RE, Kermott CA, Murad MH. Gynecomastia-evaluation and current treatment options. Ther Clin Risk Manag. 2011;7:145–8. - PMC - PubMed
    1. Daniels IR, Layer GT. Gynaecomastia. Eur J Surg. 2001;167:885–92. - PubMed
    1. Johnson RE, Murad MH. Gynecomastia: pathophysiology, evaluation, and management. Mayo Clin Proc. 2009;84:1010–5. - PMC - PubMed

Publication types